Volitionrx (VNRX) Invested Capital (2011 - 2025)
Volitionrx (VNRX) posted Invested Capital of $26970.0 for Q4 2025, down 93.01% on a QoQ basis from $385570.0 in Q3 2025, and down 77.35% year-over-year from $119084.0 in Q4 2024.
Volitionrx (VNRX) Invested Capital (2011 - 2025) Analysis & Trends
Volitionrx's Invested Capital history runs 10 years deep, the most recent figure standing at $26970.0 for Q4 2025.
- Quarterly Invested Capital fell 77.35% year-over-year to $26970.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.2 million (down 13.22% YoY) and the FY2025 annual result came in at $26970.0, down 77.35% from the prior year.
- Invested Capital was $26970.0 for Q4 2025 at Volitionrx, down from $385570.0 in the prior quarter.
- Across five years, Invested Capital topped out at $822369.0 in Q2 2021 and bottomed at $26970.0 in Q4 2025.
- A 5-year average of $383882.5 and a median of $416165.0 in 2024 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2022 — Invested Capital surged 158.51% — and 2025, when it tumbled 77.35%.
- Volitionrx's Invested Capital stood at $47301.0 in 2021, then jumped by 158.51% to $122279.0 in 2022, then fell by 6.91% to $113834.0 in 2023, then climbed by 4.61% to $119084.0 in 2024, then tumbled by 77.35% to $26970.0 in 2025.
- Business Quant data shows VNRX's Invested Capital at $26970.0 in Q4 2025, $385570.0 in Q3 2025, and $400133.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 4.41 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 499.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.79 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 1.41 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 7.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 15.00 Mn |
| 10 | Volitionrx | 109,643.10 | -2.35 Mn | - | 26,970.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26,970.00 |
| Sep 30, 2025 | 385,570.00 |
| Jun 30, 2025 | 400,133.00 |
| Mar 31, 2025 | 380,026.00 |
| Dec 31, 2024 | 119,084.00 |
| Sep 30, 2024 | 416,165.00 |
| Jun 30, 2024 | 411,645.00 |
| Mar 31, 2024 | 427,542.00 |
| Dec 31, 2023 | 113,834.00 |
| Sep 30, 2023 | 441,669.00 |
| Jun 30, 2023 | 467,223.00 |
| Mar 31, 2023 | 476,894.00 |
| Dec 31, 2022 | 122,279.00 |
| Sep 30, 2022 | 450,037.00 |
| Jun 30, 2022 | 492,173.00 |
| Mar 31, 2022 | 533,346.00 |
| Dec 31, 2021 | 47,301.00 |
| Sep 30, 2021 | 759,507.00 |
| Jun 30, 2021 | 822,369.00 |
| Dec 31, 2020 | 73,407.00 |